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Actinobacteria provide a rich spectrum of bioactive natural products and therefore
display an invaluable source towards commercially valuable pharmaceuticals and
agrochemicals. Here, we studied the use of inorganic talc microparticles (hydrous
magnesium silicate, 3MgO·4SiO2·H2O, 10 µm) as a general supplement to enhance
natural product formation in this important class of bacteria. Added to cultures of
recombinant Streptomyces lividans, talc enhanced production of the macrocyclic
peptide antibiotic bottromycin A2 and its methylated derivative Met‐bottromycin
A2 up to 109mg L−1, the highest titer reported so far. Hereby, the microparticles
fundamentally affected metabolism. With 10 g L−1 talc, S. lividans grew to 40%
smaller pellets and, using RNA sequencing, revealed accelerated morphogenesis and
aging, indicated by early upregulation of developmental regulator genes such as
ssgA, ssgB, wblA, sigN, and bldN. Furthermore, the microparticles re‐balanced the
expression of individual bottromycin cluster genes, resulting in a higher macro-
cyclization efficiency at the level of BotAH and correspondingly lower levels of non‐
cyclized shunt by‐products, driving the production of mature bottromycin. Testing a
variety of Streptomyces species, talc addition resulted in up to 13‐fold higher titers
for the RiPPs bottromycin and cinnamycin, the alkaloid undecylprodigiosin, the
polyketide pamamycin, the tetracycline‐type oxytetracycline, and the anthramycin‐
analogs usabamycins. Moreover, talc addition boosted production in other actino-
bacteria, outside of the genus of Streptomyces: vancomycin (Amycolatopsis japonicum
DSM 44213), teicoplanin (Actinoplanes teichomyceticus ATCC 31121), and the
angucyclinone‐type antibiotic simocyclinone (Kitasatospora sp.). For teicoplanin, the
microparticles were even crucial to activate production. Taken together, the use of
talc was beneficial in 75% of all tested cases and optimized natural and hetero-
logous hosts forming the substance of interest with clusters under native and
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synthetic control. Given its simplicity and broad benefits, microparticle‐
supplementation appears as an enabling technology in natural product research of
these most important microbes.
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1 | INTRODUCTION
Natural products are chemically diverse molecules that are synthe-
tized by living organisms (Harvey, 2000). Many of them have potent
pharmacological activities, which has enabled the development of
antibiotics (Fleming, 2001), anticancer drugs (Arcamone et al., 1969),
immunosuppressants (Vézina et al., 1975), infectants (Campbell
et al., 1983), and various agrochemicals, including herbicides (Bayer
et al., 1972), insecticides (Butterworth & Morgan, 1968), and fungi-
cides (Takeuchi et al., 1958). During the last century, natural pro-
ducts and their derivatives have greatly helped to double human life
expectation (Demain, 2006) and display more than 50% of today's
approved drugs (Cragg & Newman, 2013). However, drug develop-
ment from natural products is declining, partly caused by unreliable
access and supply, leading inter alia to cost and profit concerns
among pharmaceutical companies (Li & Vederas, 2009).
Actinobacteria display the most important microbial source of
natural products and therefore offer an immense treasure (Barka
et al., 2016). The genus Streptomyces provides more than two‐third of
all known antibiotics of microbial origin (Bibb, 2013) and more than
half of the FDA‐approved antibacterial natural products (Patridge
et al., 2015) but also related actinobacteria such as Micromonospora,
Actinoplanes, and Amycolatopsis (Barka et al., 2016) have emerged as
producers of potent bioactive molecules. Unfortunately, actino-
bacteria produce natural products often in minute amounts, making
even structural identification almost impossible, or do not form them
at all under laboratory conditions (Ren et al., 2017). Moreover,
natural products exhibit complex, highly diverse biosynthetic path-
ways and structures (Figure 1), which complicates efforts to
streamline and enhance production (Hanson, 2003). Towards opti-
mized supply, general strategies that allow to enhance natural pro-
duct formation in actinobacteria are highly desired.
At this point, a promising line of research seems to exploit the
link between natural product formation and the unique morpholo-
gical life cycle of actinobacteria (Chater, 1984), which differentiates
them from most other bacteria (Barka et al., 2016). In liquid culture,
their morphological development starts from germinated spores that
grow into a vegetative mycelium by linear tip extension and hyphae
branching (Chater & Losick, 1997; van Dissel et al., 2014), followed
by the formation of an aerial mycelium, which finally differentiates
into uninucleoid cells that develop again into spores (Angert, 2005).
Recently, we discovered that supplementation with inorganic
talc microparticles (hydrous magnesium silicate, 3MgO·4SiO2·H2O)
reprogrammed recombinant Streptomyces albus J1074/R2 to live a
life of accelerated morphogenesis, which enabled a three‐fold en-
hanced production of the antituberculosis polyketide pamamycin
(Kuhl et al., 2020).
Here, we took this approach further. Exemplified for re-
combinant Streptomyces lividans TK24 DG2‐Km‐P41hyg + (Horbal
et al., 2018), the effects of talc were elucidated using transcriptomics
and metabolomics together with detailed analysis of strain physiol-
ogy and morphology. The recombinant producer, representing one of
the most prestigious Streptomyces species used industrially (Sevillano
et al., 2016), formed the ribosomally and posttranslationally modified
peptide (RiPP) bottromycin under control of synthetic promoters,
supposed to uncouple production from the morphological cell cycle.
It displayed the leading cell factory to produce bottromycin (Vior
et al., 2020). The cyclopeptide was first isolated from cultures of
Streptomyces bottropensis (Waisvisz et al., 1957) and is active against
methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant
Enterococci (Kobayashi et al., 2010). Its complex biosynthesis in-
volves a unique posttranslational macrocyclization step (Huo
et al., 2012) and has posed enormous challenges on bottromycin
research and development over the past decades (Kazmaier, 2020).
Finally, the microparticle approach was scaled down to the mi-
crotiter plate scale to investigate its potential in overproducing
twelve natural compounds of commercial interest from ten major
structural classes in native and metabolically engineered actino-
bacteria, including various Streptomyces but also other genera and
families (Figure 1).
2 | MATERIALS AND METHODS
2.1 | Strains
All strains used in this study are listed in Table 1. For strain main-
tenance, spores were collected from agar plate cultures after five‐day
incubation at 30°C, resuspended in 20% glycerol, and kept at −80°C.
2.2 | Media
Mannitol‐soy flour agar was used for plate cultures of all strains. It
contained per liter: 20 g mannitol (Sigma‐Aldrich), 20 g soy flour
(Schoenenberger Hensel), and 20 g agar (Becton & Dickinson). For
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F IGURE 1 Natural products and their derivatives investigated in this study. The compounds comprise nine different chemical classes and
have been previously described in different actinobacteria: Streptomyces albus pCinCatInt (cinnamycins) (Lopatniuk et al., 2017), Streptomyces
lividans TK24 DG2‐Km‐P41hyg + (bottromycins) (Horbal et al., 2018), Streptomyces lividans TK24 (undecylprodigiosin) (Horinouchi &
Beppu, 1984), Kitasatospora sp. (simocyclinones) (Bilyk et al., 2016) Streptomyces albus J1074/R2 (Rebets et al., 2015), Streptomyces sp. IB2014/
011‐12 (alpiniamides) (Paulus et al., 2018), Amycolatopsis orientalis (vancomycin) (Zmijewski & Briggs, 1989), Actinoplanes teichomyceticus ATCC
31121 (teicoplanin) (Horbal et al., 2012), Streptomyces albus subsp. chlorinus NRRL B‐24108 (nybomycin) (Rodriguez Estevez et al., 2018),
Streptomyces rimosus ATCC 10970 (oxytetracycline) (Pethick et al., 2013), Streptomyces sp. IB2014/016‐6 (perquinolines) (Rebets et al., 2019),
Streptomyces lividans ΔYA9 (usabamycins) (Ahmed et al., 2020)[Color figure can be viewed at wileyonlinelibrary.com]
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liquid pre‐cultures and main cultures, different growth media were
used to meet the specific physiological demand of the investigated
cells, as summarized in Table 1. Liquid TSB medium (Sigma Aldrich,
pH 7.2) contained per liter: 17 g casein peptone (pancreatic), 2.5 g
dipotassium hydrogen phosphate, 2.5 g glucose, 5 g NaCl, and 3 g
soya peptone (papain digest.). Liquid SG medium (pH 7.2) contained
per liter: 20 g glucose, 10 g soytone (Becton & Dickinson), 5 g yeast
extract (Becton & Dickinson), and 2 g CaCO3. Liquid SGG medium
(pH 7.2) contained per liter: 10 g soluble starch (Sigma‐Aldrich), 10 g
glycerol, 2.5 g corn steep powder (Sigma‐Aldrich), 5 g bacto peptone
(Becton & Dickinson), 2 g yeast extract (Becton & Dickinson), 1 g
NaCl, and 21 g MOPS. Liquid DNPM medium (pH 6.8) contained per
liter: 40 g dextrin, 7.5 g soytone (Becton & Dickinson), 5 g yeast ex-
tract (Becton & Dickinson), and 21 g MOPS. Liquid GOTC medium
(pH 7.0) contained per liter: 28 g corn starch (Sigma‐Aldrich), 42 g
soybean flour (Sigma‐Aldrich), 6 g (NH4)3PO4, 2 g MgCl2, 1.5 g NaCl,
7.3 g CaCO3, 10ml 1% ZnSO4, and 3.75ml 1% MnSO4. Talc (hydrous
magnesium silicate, 3MgO · 4SiO2 · H2O, 10 µm, Sigma‐Aldrich) was
resuspended in 50mM Na‐acetate buffer (pH 6.5), autoclaved at
121°C for 20min, and added to the sterile medium before inocula-
tion of selected microparticle experiments as given below (Kuhl
et al., 2020).
2.3 | Cultivation
One loop of spores was scratched from a 5‐day‐old plate culture
(incubated at 30°C) and used to inoculate a liquid pre‐culture, which
was grown overnight in a 500ml baffled shake flask, filled with 50ml
medium and 30 g soda‐lime glass beads (5 mm, Sigma‐Aldrich). When
the pre‐culture had reached the late exponential phase, cells were
collected (8500×g, room temperature, 5 min), resuspended in 10ml
fresh medium, and used to inoculate the main cultures, either con-
taining talc or not. Main cultures were grown in shake flasks and in
deep‐well flower plates, respectively. Shake flask cultures were in-
cubated in 500ml baffled shake flasks (50ml medium) on a rotary
shaker (28°C, 230 rpm, 75% relative humidity, 5 cm shaking dia-
meter, Multitron, Infors AG). For miniaturized screening, cells were
grown in 48‐well flower plates (1 ml medium) using a benchtop in-
cubator (28°C, 1300 rpm, 75% relative humidity, BioLector m2p
labs). All experiments were conducted as biological triplicate.
2.4 | Quantification of cell concentration
The cell dry weight (CDW) of S. lividans was measured as follows.
Cells were collected (10,000×g, 4°C, 10 min), washed twice with
15 ml deionized water, and freeze‐dried (Kuhl et al., 2020). Sub-
sequently, the dry biomass was gravimetrically determined (Gläser
et al., 2020). In microparticle cultivations of S. lividans, biomass
data were corrected for the amount of talc added (Kuhl
et al., 2020)
2.5 | Quantification of glucose
Glucose was quantified by HPLC (1260 Infinity Series, Agilent), using
an Aminex HPX‐87H column (300 × 7.8 mm; Bio‐Rad) as stationary
phase and 7mM H2SO4 as mobile phase (55°C, 0.7 ml min
−1). Re-
fraction index measurement was used for detection, and external
standards were used for quantification (Kuhl et al., 2020).
2.6 | Microscopy
The 5 µl culture broth was transferred onto a glass for bright‐field
microscopy (Olympus IX70 microscope). The software ImageJ 1.52
(Schneider et al., 2012) was used to automatically determine the size
TABLE 1 Strains and natural products investigated in this study and corresponding culture conditions
Strain Natural product Medium Reference
Streptomyces albus J1074/R2 Pamamycins SGG Rebets et al. (2015)
Streptomyces lividans TK24 DG2‐Km‐P41hyg+ Bottromycins Undecylprodigiosin SG Horbal et al. (2018)
Streptomyces rimosus ATCC 10970 Oxytetracycline GOTC ATCC
Streptomyces albus pCinCatInt Cinnamycins TSB Lopatniuk et al. (2017)
Streptomyces albus subsp. chlorinus NRRL B‐24108 Nybomycin Usabamycins DNPM Myronovskyi et al. (2020)
Streptomyces sp. IB2014/011‐12 Alpiniamides TSB Paulus et al. (2018)
Streptomyces sp. IB2014/016‐6 Perquinolines TSB Rebets et al. (2019)
Amycolatopsis japonicum DSM 44213 Vancomycin TSB DSMZ
Actinoplanes teichomyceticus ATCC 31121 Teicoplanin TSB ATCC
Kitasatospora sp. DSM 102431 Simocyclinones TSB DSMZ
Abbreviations: ATCC, American Type Culture Collection; DSMZ, Deutsche Stammsammlung für Mikroorganismen und Zellkulturen (German Collection
of Microorganisms and Cell Cultures).
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of pellets formed during growth (Kuhl et al., 2020). At least 150
aggregates were analyzed per sample.
2.7 | Natural compound extraction and
quantification
The different natural products investigated in this study (Table 1) were
extracted from culture broth using a two‐step process (Kuhl
et al., 2020). In short, 500 µl broth was mixed with 500 µl acetone and
incubated for 15min (1000 rpm, room temperature, Thermomixer F1.5,
Eppendorf). Subsequently, ethyl acetate (500 µl) was added to extract
bottromycin, undecylprodigiosin, pamamycins, vancomycin, teicoplanin,
alpiniamides, perquinolines, simocyclinones usabamycins, and nybomy-
cin, respectively, whereas 1‐butanol (500 µl) was added to extract cin-
namycins and thioholgamide A. Each mixture was incubated for 15min
under the same conditions. Afterward, the organic phase was collected
(20,000×g, room temperature, 5min), and the solvent was evaporated
under a laminar nitrogen stream. Extracts were re‐dissolved in me-
thanol and clarified from debris (20,000×g, 4°C, 10min). Subsequently,
the analytes of interest were quantified, using HPLC‐ESI‐MS (C18
column, Vision HT C18 HighLoad, 100 × 2mm, 1.5 µm, Dr. Maisch,
Ammerbuch‐Entringen, Agilent Infinity 1290, AB Sciex QTrap 6500).
The individual chromatographic and mass spectrometric settings for
each investigated compound are summarized in Table S1. To extract
oxytetracycline, 250 µl culture broth was adjusted to pH 1.5 with 37%
HCl and centrifuged twice (21,000×g, 15min, 4°C). The resulting su-
pernatant was analyzed by HPLC (Agilent 1260 Infinity Series, Agilent
Technologies) on a C18 column (Nucleodur C18 Isis, 100 × 3mm, 3 µm,
Macherey‐Nagel). Oxytetracycline was detected by a diode array de-
tector (275 nm), and external standards were used for quantification.
2.8 | Extraction and quantification of intracellular
amino acids
Intracellular amino acid sampling was done using fast vacuum filtration
with nitrocellulose filters (0.2 µm pore size, Sartorius) (Wittmann
et al., 2002). After vacuum filtration of 1ml culture broth through a
nitrocellulose filter (0.2 µm pore size, Sartorius), the cell‐containing filter
was washed twice with 15ml 1.5% NaCl, transferred into a plastic cup
containing 2ml 200 µM α‐aminobutyrate as internal standard for later
quantification, and incubated 15min at 100°C for amino acid extrac-
tion. Subsequently, the obtained extract was cooled on ice, and clarified
from debris (20,000×g, 4°C, 5min). The amino acids were quantified by
HPLC using α‐aminobutyrate as internal standard and pre‐column de-
rivatization with o‐phthaldialdehyde (Schwechheimer et al., 2018).
2.9 | Transcriptome analysis
Total RNA was isolated using the Quick‐RNA Miniprep Plus kit
(Zymo Research). After DNase treatment, the obtained RNA was
purified (RNA Clean & Concentrator‐5 kit, Zymo Research) and
quantified (DropSense 16, Trinean NV). The quality of the RNA was
validated (RIN > 9) (RNA 6000 Nano kit, Agilent 2100 Bioanalyzer,
Agilent Technologies). To construct whole transcriptome com-
plementary DNA (cDNA) libraries, 2.5 μg of total RNA each was
depleted of ribosomal RNA (rRNA) (Ribo‐Zero rRNA Removal Kit
(Bacteria), Illumina). Successful rRNA removal was validated (Agilent
RNA Pico 6000 kit, Agilent 2100 Bioanalyzer, Agilent Technologies).
The obtained messenger RNA (mRNA) was converted into a cDNA
library according to the TruSeq Stranded mRNA Sample Preparation
guide (Illumina). Appropriate cDNA quality and quantity was
validated (Agilent High Sensitivity DNA kit, Agilent 2100 Bioanaly-
zer, Agilent Technologies). Sequencing was performed on an Illumina
HiSeq. 1500 instrument using 70 bases read length (Illumina).
The obtained reads were mapped to the S. lividans D/G2 genome
sequence (CP071123), which is based on the re‐annotated S. lividans
TK24 genome (Droste et al., 2021), using BOWTIE2 under standard
settings (Langmead & Salzberg, 2012), except for increasing the
maximally allowed distance for paired reads to 600 bases. To
visualize read alignments, the software READXPLORER 2.2.3 (Hilker
et al., 2016) was used. To count reads mapping to gene features,
FEATURECOUNTS v.2.0.0 (Liao et al., 2014) was applied using the
parameters ‐M ‐O, and ‐s 1. Quality control of the processed data
sets was performed using DESEQ. 2 (Love et al., 2014), including
calculation of sample‐to‐sample distances and principal component
analysis. In addition, DESEQ. 2 was used to calculate DGE data sets.
Raw data sets (sequenced reads) as well as processed data sets
(input matrix and normalized read counts from DESEQ. 2) are
available from GEO (GSE168044). For statistical analysis, Student's
t‐test was carried out and the data were filtered for genes with a
log2‐fold change ≥ 1 (p ≤ 0.05) (Kuhl et al., 2020). RNA extraction and
sequencing were conducted as biological triplicates for each strain.
3 | RESULTS
3.1 | Microparticles enhance the production of
bottromycin A2, methyl‐bottromycin A2, and
undecylprodigiosin in recombinant S. lividans
To investigate the effect of the microparticles in detail, a
bottromycin‐producing mutant of S. lividans was studied in liquid
culture with 10 g L−1 talc (Figure 2), an amount recently found op-
timal for the related strain S. albus J1074/R2 (Kuhl et al., 2020).
A culture without talc served as control. The recombinant strain
S. lividans TK24 DG2‐Km‐P41hyg+ expressed a refactored version of
the bot cluster from S. sp. BC16019 (Huo et al., 2012) under control
of two back‐to‐back synthetic promoters (Horbal et al., 2018). In the
control culture, the strain grew from early on and reached a max-
imum biomass concentration of 7.4 (g CDW) L−1 after 48 h
(Figure 2a). Then, growth stopped. However, the cells continued to
consume glucose which was depleted after 120 h. The mature bot-
tromycins, that is, bottromycin A2 and methyl‐bottromycin A2,
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started to accumulate after approximately 20 h. The two products
reached final titers of 42mg L−1 and 35mg L−1, respectively. In
contrast, bottromycin B and D were not observed. Alongside bot-
tromycin, S. lividans formed undecylprodigiosin, a native alkaloid (van
Wezel et al., 2000). The production of the latter started after 48 h
and continued until the end of the process.
In comparison, the microparticle supplemented culture achieved
significantly increased product titers. The final level of bottromycin
A2 (60mg L−1) was 43% higher than that in the control, while the
methyl‐bottromycin A2 titer (46mg L−1) was increased by 31%. In-
creased product levels already occurred after 48 h. In addition, un-
decylprodigiosin production was increased by the particle
supplementation (particularly during later stages of the cultivation)
and resulted in a 64% increased final titer. The enhanced accumu-
lation of the red pigment was even visible by the eye (Figure 3).
Talc‐supplemented cells appeared red, while cells from the control
culture were less‐intensively colored.
Interestingly, biomass formation and glucose consumption re-
mained rather unchanged between the talc‐supplemented culture
and the control. However, talc had a major impact on cellular mor-
phology. Grown without talc, the recombinant producer formed
larger pellets with an average diameter of 390 ± 118 µm (Figure 3),
while cellular aggregates in the talc supplied culture were
significantly smaller and exhibited a 40% reduced pellet diameter of
279 ± 49 µm. In later stages of the cultivation, the morphology dif-
fered also in inner structure (Figure S1). The cell aggregates in the
control reached up to 1mm in diameter and pellets appeared de-
composed inside. Pellets of the talc culture were less than half in size
and exhibited an intact and denser structure. Further tests revealed
a production optimum for total bottromycins (109 ± 24mg L−1) at
15 g L−1 talc (Figure S2). Higher talc levels were found detrimental.
3.2 | Microparticles do not affect bottromycin
precursor availability during initial ribosomal
translation but significantly change the abundance of
intermediates of the posttranslational modification
pathway
We hypothesized that the increased bottromycin titers could result
from a higher precursor availability, as recently shown for other
natural products (Gläser et al., 2020; Kuhl et al., 2020; Ser
et al., 2016; Tang et al., 1994; Thykaer et al., 2010). Therefore, we
analyzed the level of intracellular amino acids during growth (12 h,
Figure 4b) and production (48 h, Figure 4c), including the building
blocks of mature bottromycin A2: glycine, L‐proline, L‐valine,
L‐phenylalanine, L‐aspartate, and L‐cysteine (highlighted in blue in
Figure 4b,c). Talc microparticles had virtually no effect: all in-
tracellular amino acid pools remained unchanged. Generally,
L‐glutamate was most abundant, followed by L‐alanine. Taken to-
gether, talc‐enhanced bottromycin production was obviously not
triggered by increased amino acid availability at the level of the
initial ribosomal formation of the peptide backbone.
However, the talc particles affected the accumulation of bio-
synthetic intermediates from the posttranslational part of the bio-
synthetic pathway, including pre‐forms of bottromycin and so‐called
shunt (degradation) products which appeared in addition to the
mature bottromycins (carrying all major posttranslational modifica-
tions) (Figure 4a). Talc significantly increased the abundance of the
pre‐forms, that is, nonmethylated pre‐bottromycin (m/z 855.4) and
methylated pre‐bottromycin (m/z 869.4). In contrast, the level of
incomplete precursor peptides (m/z 452.2) was substantially reduced
by talc addition, and non‐cyclized shunt products exhibited a similar
trend, although less significant.
3.3 | Microparticles rebalance the expression of
individual bottromycin cluster genes
It was now interesting to see how bottromycin synthesis was af-
fected on the transcriptional level. For this purpose, global tran-
scription profiling of bottromycin‐producing S. lividans was
performed using RNA sequencing (Figure S3). The transcriptome of a
talc supplied culture (10 g L−1) was compared to that of a control at
different stages of the cultivation: exponential growth (12 h), early
production (24 h), and main production (48 h). Sample‐level quality
F IGURE 2 Impact of talc microparticles on growth and natural
product formation in Streptomyces lividans TK24 DG2‐Km‐P41hyg+.
The data show growth and production dynamics of a control culture
without microparticles (a) and a microparticle‐supplemented culture
(10 g L−1 talc) (b). The arrows indicate the sampling time points for
metabolome analysis (pre‐bottromycins, bottromycin shunt products,
intracellular amino acids), transcriptome analysis (RNA sequencing),
and/or morphology analyzes. n = 3 [Color figure can be viewed at
wileyonlinelibrary.com]
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control revealed excellent reproducibility (Figures 5 and S4). The
individual replicates of all samples closely clustered together so that
the observed expression differences could be fully attributed to the
different experimental conditions. During early production, the ex-
pression of all bottromycin cluster genes remained unchanged in the
control, whereas botP, was upregulated in the talc culture (2.0‐fold)
(Figure 6). During the main production phase, most bottromycin
cluster genes were changed in expression. Obviously, the micro-
particles re‐balanced the expression of the cluster in the microbe:
botAH was specifically increased in the talc culture (2.4‐fold) and
botC and botA remained constant, while the latter two genes were
found upregulated in the control (2.1‐fold and 2.3‐fold, respectively).
Other genes equally behaved under both conditions: botRMT1 was
downregulated (0.4‐fold), whereas botCD, botH, botT, botRMT2, and
botRMT3 remained unaffected over the entire process. It was in-
teresting to note that the expression of the cluster was only weakly
driven by the synthetic promoters (Figure S5a), but largely relied on
the promoter of the hygromycin marker gene hygR (PhygR), inserted in
between them (Figure S5b). In addition, a so far unknown but ap-
parently even stronger promoter downstream of hygR, designated
PAS, transcribed the cluster in the opposite (antisense) direction
(Figure S5c).
3.4 | Microparticles accelerate morphological
development and aging of S. lividans
On a global level, talc‐supplied and non‐supplied cells massively
changed their gene expression during the process (Figure S3). In the
control culture, 5% of all 7751 genes (414) were modulated in ex-
pression during the shift from growth to early production. The
number of altered genes was increased to 2790 (36%) during the
main production phase indicating a major shift of the cellular
program at this stage. The expression changes, observed after 48 h,
included prominent regulators of morphology and secondary meta-
bolism, such as ssgAB, chpABCDEFGH, rdlAB, rarABCDE, eshA, and
corresponding sigma factors (Tables 2 and 3), indicating ongoing
morphological development and aging of the liquid‐culture, a typical
behavior of Streptomycetes, also observed in other species (van
Dissel et al., 2014).
For the talc‐amended culture, the transcription profile chan-
ged faster, and the dynamics involved more genes (Figure S3). The
observed changes were related to the cultivation stage (Figure 5).
Notably, the microparticles accelerated the shift in expression,
leading to specific differences already during early production
which indicated an accelerated morphological development. The
number of genes, altered in expression after 24 h in the micro-
particle culture (1094 genes, 14%), was almost three times higher
than that in the control. Key morphology genes and regulators,
including ssgA (SLIV_18635, 3.3‐fold), ssgB (SLIV_30050, 2.0‐fold),
wblA (SLIV_20395, 2.8‐fold), sigN (SLIV_18240, 2.5‐fold), and bldN
(SLIV_21180, 3.2‐fold, among others, were exclusively activated
after 24 h in the presence of talc (Tables 2 and 3). In addition,
various native biosynthetic genes for secondary metabolites were
upregulated by talc at this early stage (Figure S6). During the main
production after 48 h, the expression level of genes associated to
morphology and secondary metabolism appeared rather similar
with and without talc, although slight differences remained and
totally more genes (38%, 2979) were modulated in the talc pro-
cess. Interestingly, not even one single gene showed a significantly
altered expression with talc supply during the growth phase
(Figure S4).
F IGURE 3 Impact of talc microparticles on the cellular morphology of Streptomyces lividans TK24 DG2‐Km‐P41hyg + in liquid culture.
The data show the average pellet diameter of a microparticle‐supplemented culture (10 g L−1 talc) and a control culture without microparticles
at production start (24 h) (a, ***p < 0.001, n = 150). In addition, the pellet color of control culture and talc supplied culture after 5 days of
incubation is shown, reflecting enhanced production of the red pigment undecylprodigiosin in the presence of talc (b) [Color figure can be
viewed at wileyonlinelibrary.com]
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F IGURE 4 Metabolomic impact of talc microparticles on bottromycin‐producing Streptomyces lividans TK24 DG2‐Km‐P41hyg+. The data
show relative changes in the level of bottromycin pathway intermediates (a) and intracellular amino acids (b), (c), upon addition of talc
microparticles to the medium (10 g L−1). (a) The data show pre‐bottromycin (m/z = 855.4), methylated pre‐bottromycin (m/z = 869.4), four shunt
products (m/z = 452.2, m/z = 599.4, m/z = 873.5, and m/z = 887.5), final mature bottromycin A2 (m/z = 823.4), and methylated‐bottromycin
A2 (m/z = 837.4), previously described (Crone et al., 2016; Vior et al., 2020). The data reflect the production start (24 h) and the major
production phase (48 h), and the control culture (without talc), set to 100%, is shown as dashed line (*p ≤ 0.05, **p ≤ 0.01). The intracellular
amino acid pools reflect the growth phase (12 h, b) and the major production phase (48 h, c). The amino acids that are incorporated into mature
bottromycins (L ‐glycine, L‐proline, L‐valine, L‐phenylalanine, L‐aspartate, and L‐cysteine) are highlighted in blue. The intracellular amino acid
pools during early production were not found significantly changed (data not shown) [Color figure can be viewed at wileyonlinelibrary.com]
F IGURE 5 Statistical evaluation of gene expression profiles of Streptomyces lividans TK24 DG2‐Km‐P41hyg + using PCA. Global
transcription profiling of the cultures was conducted using RNA sequencing during growth (12 h) and bottromycin production (24 h, 48 h) in the
presence of talc (10 g L−1) and without talc (control). For calculation of normalized read counts, the raw read count data were processed by
DESeq. 2 (Love et al., 2014), including regularized log transformation (with blind dispersion estimation enabled). Subsequently, PCA was
performed and visualized using ggplot2 (Wickham et al., 2016). n = 3 [Color figure can be viewed at wileyonlinelibrary.com]
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3.5 | The addition of talc to various Streptomyces
cultures enhances the formation of natural products
up to thirteen‐fold
Given the stimulating effects of microparticles on bottromycin pro-
duction in S. lividans (this study) and pamamycin production in
S. albus (Kuhl et al., 2020), we now tested the concept on a broader
scale. To facilitate the screening, we miniaturized production and
established cultures at the microliter scale in a parallelized microtiter
plate incubator. For appropriate mixing and oxygen transfer, the
microtiter plates contained flower‐shaped wells, optimized in geo-
metry for the applied 3mm shaking diameter of the instrument
(Funke et al., 2009). To validate the microliter scale against con-
ventional shake flasks, a first round of experiments was conducted
for S. lividans TK24 DG2‐Km‐P41hyg + (Figure 2) and S. albus
J1074/R2 (Kuhl et al., 2020), for which the stimulating microparticle
effects had been already proven in shake flasks. Both strains were
grown in microtiter plates over 5 days at different levels of talc
(0–50 g L−1) on their preferred medium (Table 1), followed by culture
harvesting, natural product extraction and HPLC‐ESI‐MS analysis. As
shown, the production of the bottromycins and undecylprodigiosin
by S. lividans TK24 DG2‐Km‐P41hyg + , as well as the production of
pamamycins by S. albus J1074/R2 was significantly enhanced by talc
(Figure 7). Obviously, the miniaturized scale yielded the same picture
as observed before for the 50mL scale in shake flasks, although
titers were somewhat lower, and it seemed appropriate to screen for
the microparticle‐based effects.
Subsequently, we investigated the production of different classes
of natural products in a variety of Streptomyces species at the minia-
turized scale including cinnamycins, another family of RiPPs (in addi-
tion to bottromycin), alpiniamides, another family of polyketides (in
addition to pamamycins), the tetracycline derivative oxytetracycline,
usabamycins of the anthramycin‐type, the tetrahydroisochinoline‐type
perquinolines, and nybomycin, exhibiting a so far unique structure
F IGURE 6 Hierarchical cluster analysis of expression dynamics of bottromycin biosynthetic pathway genes in Streptomyces lividans TK24
DG2‐Km‐P41hyg+. Samples were taken from a control and a talc supplied culture (10 g L−1) during growth (12 h), production start (24 h), and
major production phase (48 h). The expression level of the control during growth (12 h) was set as reference. The bottromycin cluster comprised
the genes botA, encoding the precursor peptide; botP, leucyl‐aminopeptidase; botC, YcaO domain protein; botRMT1, radical SAM; botRMT2,
radical SAM; botRMT3, radical SAM; botCD, YcaO domain protein; botAH, aminohydrolase; botH, hydrolase; botCYP, CYP450 enzyme;
botOMT, O‐methyl transferase; botT, multidrug transporter; botR, transcriptional regulator (Huo et al., 2012). n = 3 [Color figure can be viewed
at wileyonlinelibrary.com]
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TABLE 2 Gene expression profiling of recombinant Streptomyces lividans TK24 DG2‐Km‐P41hyg + during growth (12 h) and bottromycin












SLIV_00805 Nucleotide‐binding protein eshA 0.0 0.0 4.9 4.8
SLIV_03010 Hypothetical protein chpB 0.0 0.0 4.6 5.6
SLIV_04280 Regulatory protein absR2 0.0 0.0 3.0 4.4
SLIV_04285 Regulatory protein absR1 0.0 0.0 2.2 2.0
SLIV_09200 Response regulator redZ 0.0 0.0 1.5 1.5
SLIV_09220 Transcriptional regulator RedD redD 0.0 0.0 2.7 2.9
SLIV_09960 BldB bldB 0.0 1.2 1.2 1.1
SLIV_12810 ABC transporter integral membrane protein
BldKC
bldKC 0.0 −1.6 −1.6 −1.7
SLIV_12810 ABC transporter lipoprotein BldKB bldKB 0.0 0.0 −1.3 −1.5
SLIV_12810 ABC transporter integral membrane protein
BldKA
bldKA 0.0 0.0 −1.2 −1.5
SLIV_12835 Hypothetical protein actII‐ORF4 0.0 0.0 4.6 3.7
SLIV_14520 Two component regulator bldM 0.0 1.6 4.9 5.1
SLIV_16305 Regulatory protein afsR 0.0 1.1 1.1 1.5
SLIV_16310 Hypothetical protein afsS 0.0 0.0 0.0 0.0
SLIV_17970 Hypothetical protein bldC 0.0 0.0 1.5 1.5
SLIV_18635 SsgA ssgA 0.0 1.7 4.2 4.1
SLIV_20395 WhiB‐family transcriptional regulator wblA 0.0 1.5 4.4 4.5
SLIV_21560 Two component system response regulator absA2 0.0 0.0 −1.8 −2.0
SLIV_21565 Two component sensor kinase absA1 0.0 0.0 0.0 0.0
SLIV_21605 Transcriptional regulator cdaR 0.0 2.4 3.6 3.4
SLIV_23715 AraC family transcription regulator bldH 0.0 0.0 1.6 1.8
SLIV_24075 Secreted protein rdlB 0.0 0.0 5.1 5.2
SLIV_24080 Hypothetical protein rdlA 0.0 3.9 10.0 10.6
SLIV_24085 Hypothetical protein chpD 0.0 3.1 8.2 8.9
SLIV_24090 Hypothetical protein chpA 0.0 0.0 6.0 7.1
SLIV_24145 Putative secreted protein chpF 0.0 0.0 5.3 6.2
SLIV_24175 Hypothetical protein chpG 0.0 0.0 7.5 7.4
SLIV_28720 Putative secreted protein chpE 0.0 0.0 5.2 5.0
SLIV_29370 Putative secreted protein chpH 0.0 0.0 4.2 3.3
SLIV_29375 Secreted protein chpC 0.0 0.0 4.9 4.4
SLIV_29590 Hypothetical protein rarA 0.0 0.0 4.9 5.0
SLIV_29595 Hypothetical protein rarB 0.0 0.0 6.4 6.5
SLIV_29600 Hypothetical protein rarC 2.0 2.0 8.1 7.7
SLIV_29605 ATP‐GTP binding protein rarD 1.8 1.7 7.7 7.5
SLIV_29610 Cytochrome P450 rarE 0.0 1.8 7.8 7.8
SLIV_30050 Regulator ssgB 0.0 1.0 1.9 1.9
Note: The table lists the expression of genes involved in the regulation of morphology and secondary metabolism. The values correspond to log2‐fold
expression changes and refer to the control (12 h) as reference. n = 3.
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(Figure 7). Talc addition enhanced natural product formation in six out
of nine cases (67%) resulting in increased titers for cinnamycins,
bottromycins, undecylprodigiosin, pamamycins, oxytetracycline, and
usabamycins. In each case, a production optimum could be identified.
Interestingly, the optimal talc concentration strongly differed for each
strain and compound. Among all products, the highest increase was
observed for the alkaloid undecylprodigiosin (thirteen‐fold, at 20 g L−1
talc). For certain products, the microparticles not only influenced the
overall yield, but specifically altered the spectrum of the formed de-
rivatives. This resulted in notable changes, including enhancing and
diminishing effects on derivatives that were minor side products in the
control without talc. As example, usabamycin C production was more
than doubled by the addition of 10 g L−1 talc, whereas the deox-
ycinnamycin level was reduced three‐fold, when 20 g L−1 talc was
present.
3.6 | Microparticles boost natural product
formation across actinobacterial genera and families
Finally, the applicability of the microparticle approach was tested for
other actinobacteria, outside of the genus of Streptomyces (Figure 7).
Therefore, we examined the production of two glycopeptides
(vancomycin and teicoplanin) and one angucyclinone‐type antibiotic
(simocyclinone), which were formed by Amycolatopsis japonicum DSM
44213 (vancomycin), Actinoplanes teichomyceticus ATCC 31121
(teicoplanin), and Kitasatospora sp. (simocyclinone). Talc addition
boosted formation of all products in all three strains. Interestingly,
the
positive effects were found for native as well as for heterologous
producers. For teicoplanin, the addition of talc was even crucial since
the compound was barely detectable in the control. As a result of talc
addition, the enhancement was almost 100‐fold. As observed for the
Streptomyces strains, the optimum amount of talc was different for
the different strains.
4 | DISCUSSION
4.1 | Microparticle‐enhanced production provides
bottromycins at a next level of performance and adds
remarkable potential to drug development and
further biosynthetic studies
As shown, talc microparticles significantly increased the production
of the macrocyclic peptides bottromycin A2 and Met‐bottromycin A2
TABLE 3 Transcriptional changes of selected sigma factors in Streptomyces lividans TK24 DG2‐Km‐P41hyg + during growth (12 h) and
bottromycin production (24 h and 48 h) in the presence of talc (10 g L−1) and without talc (control)
Gene Annotation Control (24 h) Talc (24 h) Control (48 h) Talc (48 h)
SLIV_03325 Sigma factor 0.0 0.0 3.1 3.4
SLIV_03750 RNA polymerase sigma factor 0.0 0.0 3.9 4.4
SLIV_10445 RNA polymerase sigma factor WhiG 0.0 0.0 2.1 2.7
SLIV_12150 SigH protein 0.0 0.0 1.4 1.5
SLIV_14045 ECF sigma factor 0.0 0.0 −2.5 −2.1
SLIV_14515 RNA polymerase sigma factor SigD 0.0 0.0 2.8 2.9
SLIV_16170 RNA polymerase sigma factor 0.0 0.0 1.5 1.2
SLIV_16385 RNA polymerase sigma factor 0.0 1.2 2.4 2.9
SLIV_18240 RNA polymerase sigma factor SigN 0.0 1.3 2.0 1.9
SLIV_21180 ECF sigma factor BldN 0.0 1.7 6.4 6.4
SLIV_22925 RNA polymerase sigma factor SigU 0.0 0.0 3.9 5.0
SLIV_23960 sigma factor 0.0 0.0 2.5 2.2
SLIV_25360 RNA polymerase principal sigma factor HrdA 0.0 0.0 7.4 7.1
SLIV_29905 RNA polymerase sigma factor 0.0 6.4 6.7 7.2
SLIV_31410 RNA polymerase ECF sigma factor 0.0 0.0 2.3 0.0
SLIV_33600 ECF family RNA polymerase sigma factor 3.1 1.8 6.9 6.7
SLIV_33610 ECF family RNA polymerase sigma factor 0.0 0.0 2.8 2.5
SLIV_36925 Sigma factor LitS 0.0 0.0 1.7 2.4
Note: The values correspond to log2‐fold expression changes and refer to the control (12 h) as reference. n = 3.
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F IGURE 7 (See caption on next page)
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in recombinant S. lividans TK24 DG2‐Km‐P41hyg + (Figure 2).
Generally, bottromycins are difficult to obtain and their research has
developed into a “nightmare” over the past 65 years
(Kazmaier, 2020). Various homologous as well as heterologous pro-
ducers provide bottromycins only in the low milligram range and
even below 1mg L−1 (Crone et al., 2016; Horbal et al., 2018; Huo
et al., 2012). Due to this, improvement of titer and yield is regarded
crucial (Vior et al., 2020), especially as the pathway seems inefficient
in laboratory conditions (Crone et al., 2016; Eyles et al., 2018). In this
study, the refactored synthetic strain S. lividans TK24 DG2‐Km‐
P41hyg + , apparently among the top bottromycin producers avail-
able (Franz et al., 2021), reached 109mg L−1 bottromycins of the A2
type in the presence of 15 g L−1 talc, exceeding all previously re-
ported efforts. This achievement will greatly support drug develop-
ment and further biosynthetic studies of bottromycins and
derivatives therefrom (Vior et al., 2020). It also demonstrates that
the particle approach can be successfully used to boost the perfor-
mance of even top‐level microbial cell factories.
4.2 | Microparticle‐enhanced production of
bottromycins in recombinant S. lividans is supported
by re‐balanced expression of individual bottromycin
cluster genes driven by a complex promoter
architecture
The obtained genomic, transcriptomic, and metabolomic data sets
were now integrated to understand the involved molecular pro-
cesses on a systems level (Kohlstedt et al., 2014). Resequencing of
the bottromycin cluster verified the previously designed architecture
with a synthetic bidirectional promotor cassette in between the left
and the right part of the bottromycin cluster (Horbal et al., 2018).
While precursor availability on the amino acid level could be ruled
out as a limiting factor (Figure 4b,c), the talc‐induced increase of pre‐
bottromycins together with the simultaneous decrease of non‐
cyclized shunt products from the upper pathway, indicated a higher
efficiency of the posttranslational modification process (Figure 4a).
Notably, this was accompanied by a few significant changes in gene
expression. Previous studies showed that the main limiting factor in
bottromycin production, at least in the native host S. scabies, is the
posttranslational maturation of the precursor peptide (Vior
et al., 2020) and that the pathway inefficiently stalls at numerous
biosynthetic steps (Crone et al., 2016). We conclude that the
increased production efficiency in talc‐supplied cultures largely
resulted from the specifically increased expression of the aminohy-
drolase of the cluster (encoded by botAH, 2.4‐fold, 48 h, Figure 6),
responsible for the unique amidine‐forming macrocyclodehydration
of the molecule (Huo et al., 2012). Since this step follows after
β‐methylation of the valine, proline, and phenylalanine residues in
the forming peptide, catalyzed by BotRMT1, BotRMT2, and
BotRMT3 (Figure 6), this link nicely explains that the titer of both
bottromycin derivatives was increased simultaneously (Crone
et al., 2016; Horbal et al., 2018).
It appears likely that also the lower abundance of botA, encoding
for precursor peptide (Figure 6) helped to balance biosynthesis, as
previous attempts to increase precursor peptide levels were not found
suitable to trigger bottromycin A2 synthesis, (Horbal et al., 2018; Vior
et al., 2020). Taken together, fine‐tuned re‐balancing of the expression
of individual cluster genes obviously mediated the improved biosynth-
esis. This picture differs largely from that obtained for talc‐enhanced
pamamycin production in S. albus, where the entire gene cluster was
activated, up to 1000‐fold (Kuhl et al., 2020). Likely, the difference
originated from the different expression control strategies: the ex-
pression control of the bottromycin cluster in S. lividanswas of synthetic
nature (Horbal et al., 2018), whereas the pamamycin cluster was ex-
pressed under its native control (Kuhl et al., 2020). Hereby, it appeared
surprising that the bottromycin cluster was affected at all, as the syn-
thetic design was expected to uncouple expression from the host me-
tabolism. A close inspection of the RNA sequencing data revealed that
the expression control was much more complex than expected
(Figure S5). It was only weakly driven by the synthetic promoters but
largely relied on the highly active promoter of the hygromycin marker
gene hygR, inserted in between of them, and transcribing the right
cluster genes (Figure S5b). In addition, a so far unknown but apparently
even stronger antisense promoter sequence (PAS) downstream of hygR,
transcribed the cluster in the opposite direction and expressed the left
cluster genes, plus an additional antisense transcript of hygR
(Figure S5c). These previously not considered promoters created a
F IGURE 7 Impact of talc microparticles on nine major classes of natural products across different actinobacterial families. RiPP‐type
cinnamycins using S. albus pCinCatInt (Lopatniuk et al., 2017), RiPP‐type bottromycins using S. lividans TK24 DG2‐Km‐P41hyg + (Horbal
et al., 2018), alkaloid‐type undecylprodigiosin using S. lividans TK24 DG2‐Km‐P41hyg + (Horbal et al., 2018), angucyclinone‐type simocyclinones
using K. sp. (Bilyk et al., 2016), polyketide‐type pamamycins using S. albus J1074/R2 (Rebets et al., 2015), polyketide‐type alpiniamides using S.
sp. IB2014/011‐12 (Paulus et al., 2018), glycopeptide‐type vancomycin using A. japonicum DSM 44213 (Stegmann et al., 2014), glycopeptide‐
type teicoplanin using A. teichomyceticus ATCC 31121 (Horbal et al., 2012), nybomycin using S. albus subsp. chlorinus NRRL B‐24108 (Rodriguez
Estevez et al., 2018), tetracycline‐type oxytetracycline using S. rimosus ATCC 10970 (Pethick et al., 2013), tetrahydroisochinoline‐type
perquinolines using S. sp. IB2014/016‐6 (Rebets et al., 2019), and anthramycin‐type usabamycins using S. albus subsp. chlorinus NRRL B‐24108
(nybomycin) (Rodriguez Estevez et al., 2018). All strains were incubated over 5 days using miniaturized microtiter plate cultures (1 ml) at
different talc levels between 0 and 50 g L−1. The natural product levels were determined after solvent extraction using HPLC‐ESI‐MS and
reflect final titers after 5 days. The colored circles given beside strain names indicate the type of producers studied: native (blue circle) and
heterologous strains (orange circle). The colored squares denote the underlying control type for cluster expression: native (blue square) and
synthetic regulation (orange square). n = 3 [Color figure can be viewed at wileyonlinelibrary.com]
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complex control architecture and could play a major role in
mediating the talc‐effect.
4.3 | Microparticles affect submerged culture
morphology and accelerate morphological
development and aging of S. lividans and S. albus
The insights into the impact of talc microparticles on morpho-
logical development (Figure 4) and the associated cellular pro-
gram of S. lividans (Figures 5, 6, S4, and S6) and the picture
recently obtained for the talc effects on the related strain S. albus
(Kuhl et al., 2020), now allowed to draw a few important
conclusions related to morphology and its control in these type
of bacteria.
As shown, talc reduced the pellet size of both strains (Figure 3a)
(Kuhl et al., 2020), and this response can be expected also in other
actinobacteria (Ren et al., 2015), although exceptions cannot be ex-
cluded. From the bioengineering viewpoint, smaller pellets appear
favorable, as they reduce problems with mass and oxygen transfer
limitation, slow growth, and culture heterogeneity (Mehmood
et al., 2012; Tamura et al., 1997; van Dissel & van Wezel, 2018; van
Dissel et al., 2014).
The strength of the talc‐effect was quite different for the two
strains. While 10 g L−1 of the talc material reduced the pellet size
of S. albus more than six‐fold (Kuhl et al., 2020), the same amount
of talc did much less to S. lividans, as its pellets still maintained
60% of the size of the control culture. The stronger resistance of
S. lividans might be related to its more dense and compact
aggerates, offering less attack points for fragmentation and
segregation than the more open and loose structures of S. albus
(Zacchetti et al., 2018). In addition, differences in cell wall
composition, mechanical strength, and hydrophobicity of spores,
hyphae, and mycelia could explain the different accessibility of
these bacteria to talc‐mediated morphology engineering and
might be interesting to study further (Driouch, Roth, Dersch,
et al., 2010a, 2010b; Driouch et al., 2010; Driouch et al., 2012;
Walisko et al., 2012).
Notably, the microparticles accelerated the morphological
development of the studied Streptomyces in submerged culture.
S. lividans revealed a premature activation of regulator genes,
such as sigN, bldN, ssgA, ssgB, and wblA (Tables 2 and 3), im-
portant control elements of morphology development in Strep-
tomyces (Kang et al., 2007; Rebets et al., 2018; Traag & van
Wezel, 2008). The same picture of accelerated aging was recently
observed for talc‐treated S. albus (Kuhl et al., 2020), although the
microparticles affected the expression of a much higher number
of genes in this microbe (56% of all genes) (Kuhl et al., 2020).
S. lividans, in contrast to S. albus, does not sporulate in liquid
culture (Daza et al., 1989; Rebets et al., 2018). Differences in
morphology control and development on the species level are
likely the reason for the observed individual differences.
However, the overall response to the microparticle addition
apparently was the same for both strains: accelerated morphol-
ogy development and aging and it appears likely that other
actinobacteria will behave in a similar way.
4.4 | The use of microparticles displays a powerful
approach to support natural product research in
actinobacteria
As shown, microparticle‐based cultures revealed a notably increased
performance in producing natural products. First, the addition of talc
beneficially increased the formation of 75% of the tested natural
products, covering seven important classes with a highly diverse
structure: polyketides, glycopeptides, RiPPs, alkaloids, tetracyclines,
anthramycin‐analogs, and angucyclinone‐analogs with different
structure (Figures 1 and 7). Stimulating production was observed for
molecules of clinical relevance as antibiotics (vancomycin, oxyte-
tracycline, and teicoplanin) (Elsayed et al., 2015; Fung et al., 2012;
Liu et al., 2018) for several high‐potential candidates presently under
development into antibiotics (bottromycin, cinnamycin, pamamycin,
and simocyclinone) (Buttner et al., 2017; Kobayashi et al., 2010;
Lefèvre et al., 2004; Lopatniuk et al., 2017) and antitumor drugs
(undecylprodigiosin and usabamycin) (Sato et al., 2011; Stankovic
et al., 2014). Second, the microparticle‐approach worked on actino-
bacteria from different families, including six strains of the most
important Streptomyces group, plus representatives of the genera
Amycolatopsis, Actinoplanes, and Kitasatospora. Third, optimized per-
formance was observed for various strain backgrounds: natural
producers, heterologous hosts, and strains expressing the gene
cluster of interest under native and under synthetic control. Hereby,
one example (teicoplanin) demonstrated that microparticles can even
enable formation of a natural product, normally not observed
(Figure 7). Fourth, the approach is simple. All what is needed is to add
a little bit of talcum powder into the medium. Although the optimum
talc level differed between strains and products, a concentration
of 10 g L−1 always revealed a significant effect. Altogether,
microparticle‐enhanced cultivation provides a valuable concept for
natural product research in actinobacteria, complementing efforts to
streamline eukaryotic filamentous fungi (Böl et al., 2020; Veiter
et al., 2018).
5 | CONCLUSIONS
As shown, talc‐supplementation boosted production of seven classes of
commercially relevant natural products across strains from different
actinobacterial families, including natural as well as heterologous pro-
ducers. The improvement was up to 100‐fold. Obviously, the talc‐effect
generally accelerated morphological development and aging, inter alia
leading to enhanced expression (Kuhl et al., 2020) and re‐balanced ex-
pression (this study) of the bacterial gene clusters of interest. It is well
known that antibiotic production in Streptomyces correlates to morpho-
logical development (Chater, 1984) and certain natural products are even
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part of programmed cell death (PCD) (Tenconi et al., 2018) so that the
microparticles obviously trigger a sweet spot towards enhanced
performance.
Without doubt, the microparticle concept appears useful to be sys-
tematically applied to the field of natural product research, where it
offers several striking opportunities. Its successful application at the small
scale shows potential for screening efforts to support research on major
questions: discovery of novel molecules, activation of silent gene clusters,
supply of sufficient amounts for structure elucidation, and exploration of
biosynthetic control mechanisms, among others. The applicability to the
microliter and microtiter plate scale provides a nice extension to recent
developments on miniaturized physiological characterization of Strepto-
myces (Koepff et al., 2017). It appears promising to rescreen some of the
libraries of isolates available worldwide, adding a bit of talc (Barka
et al., 2016; Landwehr et al., 2016; Silva et al., 2020; Steele et al., 2019).
Moreover, given the enormous interest to tailor cellular morphology in
actinobacteria for improved performance (Koebsch et al., 2009; van
Dissel et al., 2014; van Wezel et al., 2006; Wang et al., 2017; Xu
et al., 2008), the microparticle addition seems useful to be tested on the
many existing actinobacterial strains, genetically not accessible (Atanasov
et al., 2021).
Regarding industrial manufacturing of natural products at large
scale, talc could provide a straightforward drop‐in solution. It is available
in huge amounts, approximately 8 million tons per year according to
recent market reviews. The material is cheap, in the range of 10 EUR
cents per kg. As an example, supplementation of a 100m3 production
process with 10 g L−1 talc (found effective) would add only costs in the
range of 100 EUR. Moreover, co‐harvested talc could upgrade fermen-
tation biomass for post‐process valorization, given its excellent perfor-
mance as coating and baking agent in fertilizer formulations (Kaji
et al., 2017) and its proven safety and efficacy as feed additive to all
animal species (Mallet et al., 2005; Rychen et al., 2018).
Furthermore, it appears interesting to explore the interaction be-
tween microparticles and cells in more detail. On the particle side, talc
prevented spore agglomeration during the initial culture phase of the
fungus Aspergillus niger, whereas chemical (nutritional) effects by leached
talc minerals played no significant role for the altered morphogenesis
(Driouch et al., 2010). Moreover, particle size and shape were found
critical. Even a small increase in particle diameter from 6 to 15µm re-
sulted in a severe loss of the morphology effects, and lamellar shaped talc
particles were found more efficient to tailor morphology than round
shaped materials (Driouch, 2009). Given the various sizes and shapes of
talc, achievable from ball, rod, and autogenous mills, more systematic
studies appear feasible. So far not explored but interesting seems the
importance of the material softness, as talc is the softest known mineral.
Hereby, several other micro materials such as aluminum oxide (Driouch
et al., 2010) and titanium silicate oxide (Driouch et al., 2012) await to be
tested. On the cellular side, an inspection of the impact of cell wall
composition, mechanical strength, and hydrophobicity of spores, hyphae,
and mycelia seems relevant, as stated above. Moreover, more
research will be needed to clarify the talc‐effects in stirred tanks and at
large scale, exhibiting different hydrodynamics and mixing regimes
(Bliatsiou et al., 2020; Kowalska et al., 2020).
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